Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

BACKGROUND: Primary sclerosing cholangitis (PSC) confers a high risk of cholangiocarcinoma (CC) development. Since patients at risk of CC may be selected for early liver transplantation, it is a challenge to identify any predisposing factors. We compared the presentation and natural history of a lar...

Podrobná bibliografie
Hlavní autoři:	Boberg, K, Bergquist, A, Mitchell, S, Pares, A, Rosina, F, Broomé, U, Chapman, R, Fausa, O, Egeland, T, Rocca, G, Schrumpf, E
Médium:	Journal article
Jazyk:	English
Vydáno:	2002

Podobné jednotky

Cholangiocarcinoma in primary sclerosing cholangitis is associated with long-standing inflammatory bowel disease. A long-term follow-up of 394 primary sclerosing cholangitis patients.
Autor: Boberg, K, a další
Vydáno: (2001)

Natural history of primary sclerosing cholangitis. A longterm follow-up study of 394 European primary sclerosing cholangitis patients
Autor: Boberg, K, a další
Vydáno: (2000)

New time dependent prognostic models for primary sclerosing cholangitis (PSC)
Autor: Rocca, G, a další
Vydáno: (2000)

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.
Autor: Boberg, K, a další
Vydáno: (2002)

The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.
Autor: Boberg, K, a další
Vydáno: (2001)

Prognostic indicators of primary sclerosing cholangitis determined by a cox phase-specific time-dependent model.
Autor: Boberg, K, a další
Vydáno: (1998)

HLA class II haplotypes in primary sclerosing cholangitis patients from five ethnic groups.
Autor: Saarinen, S, a další
Vydáno: (1998)

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.
Autor: Spurkland, A, a další
Vydáno: (1999)

Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis.
Autor: Björnsson, E, a další
Vydáno: (2002)

Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.
Autor: Bansi, D, a další
Vydáno: (1997)

Detection of antineutrophil cytoplasmic antibody in primary sclerosing cholangitis: Comparison of the alkaline phosphatase and immunofluorescent techniques.
Autor: Bansi, D, a další
Vydáno: (1996)

DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY IN PRIMARY SCLEROSING CHOLANGITIS - COMPARISON OF THE ALKALINE-PHOSPHATASE AND IMMUNOFLUORESCENT TECHNIQUES
Autor: Bansi, D, a další
Vydáno: (1995)

Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review
Autor: Annika Bergquist, a další
Vydáno: (2024-02-01)

The natural history of small-duct primary sclerosing cholangitis
Autor: Bjornsson, E, a další
Vydáno: (2007)

The natural history of small-duct primary sclerosing cholangitis.
Autor: Björnsson, E, a další
Vydáno: (2008)

Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis.
Autor: Martins, E, a další
Vydáno: (1994)

Patients with small duct primary sclerosing cholangitis have favorable long term prognosis.
Autor: Bjornsson, E, a další
Vydáno: (2001)

Primary sclerosing cholangitis.
Autor: Mitchell, SA, a další
Vydáno: (2000)

Are dominant strictures in primary sclerosing cholangitis a risk factor for cholangiocarcinoma?
Autor: Chapman, R, a další
Vydáno: (2017)

HLA associations in small-duct compared with large-duct primary sclerosing cholangitis
Autor: Naess, S, a další
Vydáno: (2012)

Diagnosis and management of primary sclerosing cholangitis.
Autor: Chapman, R, a další
Vydáno: (2010)

The management of primary sclerosing cholangitis.
Autor: Mitchell, SA, a další
Vydáno: (1998)

Primary sclerosing cholangitis
Autor: Chapman, R
Vydáno: (2007)

Primary sclerosing cholangitis.
Autor: Chapman, R
Vydáno: (1985)

Primary sclerosing cholangitis.
Autor: Cullen, S, a další
Vydáno: (2003)

Primary sclerosing cholangitis.
Autor: Williamson, K, a další
Vydáno: (2014)

Primary sclerosing cholangitis.
Autor: Worthington, J, a další
Vydáno: (2006)

Primary sclerosing cholangitis
Autor: Chapman Roger, a další
Vydáno: (2006-10-01)

Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.
Autor: Mitchell, SA, a další
Vydáno: (2001)

Ulcerative colitis: sclerosing cholangitis today, cancer tomorrow?
Autor: Broomé, U, a další
Vydáno: (1997)

Review article: the management of primary sclerosing cholangitis.
Autor: Mitchell, SA, a další
Vydáno: (1997)

The management of primary sclerosing cholangitis.
Autor: Chapman, R
Vydáno: (2003)

The immunology of primary sclerosing cholangitis.
Autor: Chapman, R
Vydáno: (1990)

Primary sclerosing cholangitis - Foreword
Autor: Chapman, R
Vydáno: (2006)

THE IMMUNOGENETICS OF PRIMARY SCLEROSING CHOLANGITIS
Autor: Chapman, R
Vydáno: (1993)

Etiopathogenesis of primary sclerosing cholangitis.
Autor: Chapman, R, a další
Vydáno: (2008)

Aetiopathogenesis of primary sclerosing cholangitis.
Autor: Cullen, S, a další
Vydáno: (2001)

Unusual Presentation of Primary Sclerosing Cholangitis
Autor: BC Pineau, a další
Vydáno: (1997-01-01)

Is the 308 polymorphism in the tumor necrosis factor (alpha) (TNF alpha) promoter region a marker of disease susceptibility in European patients with primary sclerosing cholangitis (PSC)?
Autor: Mitchell, SA, a další
Vydáno: (1998)

An update on primary sclerosing cholangitis.
Autor: Maggs, JR, a další
Vydáno: (2008)